97 related articles for article (PubMed ID: 4071432)
1. [Active pathogenetic therapy of systemic rheumatic diseases].
Nasonova VA
Ter Arkh; 1985; 57(8):3-6. PubMed ID: 4071432
[No Abstract] [Full Text] [Related]
2. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century].
Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA
Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523
[No Abstract] [Full Text] [Related]
3. Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Nakamura T; Matsuda T; Kawagoe Y; Ueda Y; Ebihara I; Koide H
Nephrol Dial Transplant; 2004 Jul; 19(7):1935-7. PubMed ID: 15199209
[No Abstract] [Full Text] [Related]
4. [Basic methods of treatment of and individual programs for patients with systemic lupus erythematosus].
Ivanova MM; Karateev DE; Luchikhina EL
Klin Med (Mosk); 2000; 78(5):45-9. PubMed ID: 10881511
[No Abstract] [Full Text] [Related]
5. [Therapy of lupus nephritis in childhood].
Taubert M; Döring E
Padiatr Grenzgeb; 1983; 22(2-3):191-4. PubMed ID: 6888932
[No Abstract] [Full Text] [Related]
6. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
7. [Combined basic immunosuppression following kidney transplantation. Cyclosporin A in combination with azathioprine and methylprednisolone].
Land W; Illner WD; Zink RA; Castro LA
MMW Munch Med Wochenschr; 1983 Apr; 125(17):361-3. PubMed ID: 6408461
[No Abstract] [Full Text] [Related]
8. [The combined intensive therapy of rheumatoid arthritis with systemic manifestations].
Oliunin IuA; Balabanova RM; Solov'ev SK; Chiklikchi AS
Ter Arkh; 1995; 67(8):59-62. PubMed ID: 7482340
[TBL] [Abstract][Full Text] [Related]
9. Treatment of systemic lupus erythematosus.
Miescher PA
Springer Semin Immunopathol; 1986; 9(2-3):271-82. PubMed ID: 3544282
[No Abstract] [Full Text] [Related]
10. [Changes in the functional activity of neutrophils during hemosorption therapy of patients with systemic rheumatic and other diseases with immunologic disorders].
Mogireva IA; Barsukov AA; Dmitriev AA; Zemskov VM
Ter Arkh; 1985; 57(8):30-3. PubMed ID: 2933840
[TBL] [Abstract][Full Text] [Related]
11. [Systemic complications in patients with rheumatism and collagen disease and their treatment].
Eguchi K
Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():106-10. PubMed ID: 11989247
[No Abstract] [Full Text] [Related]
12. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Reinhold-Keller E
Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
[No Abstract] [Full Text] [Related]
13. [Effect of hemoperfusion therapy on the system of soluble leukocyte antigens in systemic rheumatic and similar diseases].
Dmitriev AA; Shevchenko OP; Bektimirev RA; Mogireva IA
Revmatologiia (Mosk); 1987; (1):21-5. PubMed ID: 3299621
[No Abstract] [Full Text] [Related]
14. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
[TBL] [Abstract][Full Text] [Related]
16. Systemic management of dysthyroid ophthalmopathy.
Fells P
Eye (Lond); 1988; 2 ( Pt 2)():198-200. PubMed ID: 3058526
[TBL] [Abstract][Full Text] [Related]
17. [Immunomodulating therapy of collagen diseases].
Helmke K; Becker H
Immun Infekt; 1986 May; 14(3):109-14. PubMed ID: 3710515
[TBL] [Abstract][Full Text] [Related]
18. Chemical immunosuppression.
Salaman JR
Ann Clin Res; 1981; 13(4-5):307-12. PubMed ID: 7337412
[No Abstract] [Full Text] [Related]
19. Treatment of diffuse proliferative lupus nephritis: an Indian experience.
Abraham MA; Korula A; Arun KN; Jayakrishnan K; John GT; Thomas PP; Jacob CK
Natl Med J India; 1997; 10(6):273-5. PubMed ID: 9481097
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approach to the vasculitic syndromes.
Leavitt RY; Fauci AS
Mt Sinai J Med; 1986 Jun; 53(6):440-8. PubMed ID: 2876378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
